2022 Ljubljana, Slovenia

III-14 giovanni Di Veroli
Bone Remodeling QSP to Guide Clinical Trial Design of WNT pathway inhibitors
Thursday 09:50-11:20
III-20 Anubha Gupta
Characterisation of time course of response using model based meta-analysis of public domain data to support trial design in axial spondyloarthritis
Thursday 09:50-11:20
III-21 Andrew Hooker
Model-based adaptive optimal design for nonlinear mixed-effects models with model structure uncertainty. Application in a simulated dose-finding study.
Thursday 09:50-11:20
III-24 Alexander Janssen
A Bayesian Optimization Procedure for the Automated Determination of Optimal Limited Sampling Strategies
Thursday 09:50-11:20
III-32 Romain Leroux
Design evaluation and optimisation in nonlinear mixed effects models with the R package PFIM
Thursday 09:50-11:20
III-35 Claude Magnard
Optimizing the sample size of a bridging study using Simulx, an application of the MonolixSuite
Thursday 09:50-11:20
III-43 Aziz Ouerdani
Concentration-QTc analysis versus Intersection Union Test: sample size considerations for a thorough QT study
Thursday 09:50-11:20
III-45 Amr Radwan
Design of a Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Dupilumab in Children Aged 1-11 Years, With Active Eosinophilic Esophagitis
Thursday 09:50-11:20